Aimei Health Technology Co., Ltd.

CIK: 1979005•Ticker: AFJK

SPAC Overview

$69M
IPO Size
$12.5M
Trust (as of 2026-06-30)
IPO
Current Status
2023
IPO Year

Timeline Progress

About

Aimei Health Technology Co., Ltd. is a blank-check company seeking a business combination. Its intended focus is small-cap healthcare innovation businesses, particularly in biopharmaceuticals, medical technology/devices, diagnostics and related services.

Investment Focus

Healthcare, Biopharmaceuticals, Technology

Geographic Focus

North America, Europe, Asia Pacific

Embarc dashboard

What the sponsor registered, what the deal actually priced at, and every 8-K that moved it — unit structure, sponsor promote, and the dated lifecycle events, each linked to its filing.

  • Unit structure as registered and as priced — price, warrant coverage, rights, trust per unit
  • Sponsor promote: founder shares and percentage, private-placement warrants, trust deposit
  • The full 8-K lifecycle timeline, each event linked to its filing
  • Price history across the unit, share and warrant tickers
  • Follow it, and see it change on your watchlist
Open in the dashboard

SPAC Team

Extended Team Information

The team includes CEO Juan Fernandez Pascual, with automotive and industrial leadership experience and prior SPAC COO experience, and CFO Heung Ming Wong, with extensive finance, accounting and public-company director experience. Its director nominees bring experience in accounting, auditing, healthcare, business operations, private equity, and real estate.

Stock Performance

AFJKU
Trading Symbol
First Trade
2023-12-05
$10.14
Current Price
2026-10-02
$12.49
+23%

Key Information

IPO Date
2023-12-05
Total Redemptions
$44.8M
SIC
6770
SPAC Ticker
AFJK